Mia's Feed
Medical News & Research

Traditional Chinese Medicine Compound Shows Promise in Preventing Heart Artery Spasms

Traditional Chinese Medicine Compound Shows Promise in Preventing Heart Artery Spasms

Share this article

A natural compound from traditional Chinese medicine, schisandrin A, shows potential to prevent coronary artery spasms, offering new hope for heart health treatments.

2 min read

Researchers from Toho University have identified a promising natural compound, schisandrin A, derived from the traditional Chinese medicinal plant Schisandra chinensis. This compound has demonstrated a potential role in preventing coronary artery spasms — sudden constrictions of the arteries supplying blood to the heart. Such spasms, often triggered by chemical messengers like acetylcholine, histamine, and serotonin, can significantly reduce blood flow, leading to angina or even heart attacks, particularly in individuals without evident artery obstructions.

In laboratory experiments using pig coronary arteries, which closely mimic human arteries in structure and function, schisandrin A effectively relaxed arterial contractions induced by spasm-triggering agents. The mechanism involves blocking L-type calcium channels—critical in controlling muscle contraction—thus maintaining arterial relaxation by preventing excess calcium entry into smooth muscle cells. Additionally, schisandrin A exhibited mild anticholinergic properties, further inhibiting nerve signals that cause artery constriction.

This compound is a key ingredient in Shengmai San, a traditional Chinese herbal remedy used for over 700 years to support heart health. While Shengmai San has primarily been used for symptom relief, this study offers new insights into how schisandrin A might directly influence arterial behavior, potentially reducing the risk of spasms.

Although the concentrations used in the study were higher than typical bloodstream levels after oral intake, injectable formulations of Shengmai San could achieve similar therapeutic levels. This opens avenues for future research into using schisandrin A as a preventive agent against coronary artery spasms, especially in at-risk patients.

Lead researcher Dr. Keisuke Obara stated, "Our findings suggest that schisandrin A, a natural compound from traditional herbal medicine, could offer a novel approach to preventing coronary spasms. This development could contribute to lowering the global burden of ischemic heart disease." This research highlights promising prospects for integrating traditional herbal compounds into modern cardiovascular therapy.

Source: https://medicalxpress.com/news/2025-06-natural-compound-traditional-chinese-medicine.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative Autoinjector Promises Rapid Treatment for Severe Bleeding Emergencies

A groundbreaking autoinjector delivers lifesaving tranexamic acid within five minutes, enhancing emergency response in severe bleeding cases by providing fast, easy-to-administer treatment outside hospital settings.

Disparities in Kidney Transplant Access for Indigenous Australians on Dialysis

Indigenous Australians on dialysis face significant barriers to kidney transplantation, with systemic issues limiting their access to life-saving treatment. Recent Australian research highlights urgent need for targeted reforms to address these disparities.

Identification of Blood Proteins That Predict Future Cognitive Decline

New research from Singapore identifies blood proteins that can predict future cognitive decline and dementia, offering promising avenues for early detection and intervention.

Healthcare Spending Expected to Surpass Economic Growth from 2024 to 2033

Projections show US healthcare spending will outgrow the nation's GDP between 2024 and 2033, reaching over 20% of the economy by 2033. Learn about the key trends and implications.